"Analgesics, Opioid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS.
Descriptor ID |
D000701
|
MeSH Number(s) |
D27.505.696.277.600.500 D27.505.696.663.850.014.760.500 D27.505.954.427.040.550.500 D27.505.954.427.210.600.500
|
Concept/Terms |
Partial Opioid Agonists- Partial Opioid Agonists
- Agonists, Partial Opioid
- Opioid Agonists, Partial
- Opioid Partial Agonists
- Agonists, Opioid Partial
- Partial Agonists, Opioid
Full Opioid Agonists- Full Opioid Agonists
- Agonists, Full Opioid
- Opioid Agonists, Full
- Opioid Full Agonists
- Agonists, Opioid Full
- Full Agonists, Opioid
Opioid Mixed Agonist-Antagonists- Opioid Mixed Agonist-Antagonists
- Agonist-Antagonists, Opioid Mixed
- Mixed Agonist-Antagonists, Opioid
- Opioid Mixed Agonist Antagonists
|
Below are MeSH descriptors whose meaning is more general than "Analgesics, Opioid".
Below are MeSH descriptors whose meaning is more specific than "Analgesics, Opioid".
This graph shows the total number of publications written about "Analgesics, Opioid" by people in this website by year, and whether "Analgesics, Opioid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
1999 | 1 | 0 | 1 |
2002 | 1 | 2 | 3 |
2006 | 1 | 0 | 1 |
2008 | 1 | 0 | 1 |
2009 | 1 | 1 | 2 |
2010 | 4 | 0 | 4 |
2011 | 3 | 1 | 4 |
2012 | 0 | 2 | 2 |
2013 | 1 | 1 | 2 |
2014 | 1 | 2 | 3 |
2015 | 0 | 3 | 3 |
2016 | 8 | 2 | 10 |
2017 | 111 | 25 | 136 |
2018 | 95 | 48 | 143 |
2019 | 47 | 20 | 67 |
2020 | 6 | 10 | 16 |
2021 | 2 | 6 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Analgesics, Opioid" by people in Profiles.
-
Increasing Short- and Long-Term Buprenorphine Treatment Capacity: Providing Waiver Training for Medical Students. Acad Med. 2022 02 01; 97(2):182-187.
-
Pregnant Patients Using Opioids: Treatment Access Barriers in the Age of COVID-19. J Addict Med. 2022 Jan-Feb 01; 16(1):e44-e47.
-
Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication. J Addict Med. 2021 Nov-Dec 01; 15(6):516-518.
-
Unhealthy Opioid Use and COVID-19 Mortality Incidence in Older Adults: A Multicenter Research Network Study. Subst Use Misuse. 2021; 56(13):2044-2048.
-
It Is Time to Implement Primary Prevention in the Workplace to Ameliorate the Ongoing U.S. Opioid Epidemic. New Solut. 2021 11; 31(3):210-218.
-
NIOSH Responds to the U.S. Drug Overdose Epidemic. New Solut. 2021 11; 31(3):307-314.
-
Opioid overdose crises during the COVID-19 pandemic: implication of health disparities. Harm Reduct J. 2021 08 16; 18(1):89.
-
Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year. J Subst Abuse Treat. 2022 02; 133:108590.
-
Comprehensive Workplace Policies and Practices Regarding Employee Opioid Use. New Solut. 2021 11; 31(3):219-228.
-
Comparison of Medication Prescribing Before and After the COVID-19 Pandemic Among Nursing Home Residents in Ontario, Canada. JAMA Netw Open. 2021 08 02; 4(8):e2118441.